[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337661-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337661-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-novel-cuproptosis-related-genes-mediating-the-prognosis-and-immune-microenvironment-in-cholangiocarcinoma-article","Identiﬁcation of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma - Article","","Cuproptosis is described as a novel, mediated form of cell death linked to cancer progression, yet its prognostic and therapeutic role in cholangiocarcinoma remains unclear. A systematic analysis across 146 cuproptosis-related genes used independent mRNA and protein datasets to uncover mechanisms. A 10-gene prediction model showed strong prognostic value, distinguishing low- and high-cuproptosis groups with distinct tumor microenvironments, immune- and drug-sensitivity differences, and validation by qRT-PCR.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-novel-cuproptosis-related-genes-mediating-the-prognosis-and-immune-microenvironment-in-cholangiocarcinoma-article/337661/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-novel-cuproptosis-related-genes-mediating-the-prognosis-and-immune-microenvironment-in-cholangiocarcinoma-article/337661.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is cuproptosis and why is it studied in cholangiocarcinoma?","Question",{"text":63,"@type":64},"Cuproptosis is presented as a novel mediated cell death type associated with cancer progression. The document focuses on clarifying its role in cholangiocarcinoma for prognosis prediction, subgroup classification, and therapy strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the prognostic model for cholangiocarcinoma developed?",{"text":68,"@type":64},"The study performed a systematic analysis of 146 cuproptosis-related genes using independent mRNA and protein datasets. A 10-cuproptosis-related gene prediction model was constructed and evaluated for survival association.",{"name":70,"@type":61,"acceptedAnswer":71},"What differences were found between low- and high-cuproptosis groups?",{"text":72,"@type":64},"The low-cuproptosis group showed significantly better prognosis. The two groups also displayed distinct tumor microenvironments, including differences in endothelial cell proportions and cancer-associated fibroblasts, along with differences in immune checkpoint and chemotherapeutic drug sensitivities.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337661,1790384501,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Identiﬁcation of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma  \nQiang Liu, PhD 1,2,3,\\#, Jianpeng Zhu, MS2,\\#, Zhicheng Huang, MS2, Xiaofeng Zhang, PhD 1,2,3,4,5*, and Jianfeng Yang, PhD 1,2,3,4,5*   \nTechnology in Cancer Research & Treatment  \nVolume 23: 1-16  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338241239139](DOI: 10.1177/15330338241239139)[ ](DOI: 10.1177/15330338241239139)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nAbstract  \nBackground: Cuproptosis is a novel type of mediated cell death strongly associated with the progression of several cancers and has been implicated as a potential therapeutic target. However, the role of cuproptosis in cholangiocarcinoma for prognostic prediction, subgroup classiﬁcation, and therapeutic strategies remains largely unknown. Methods: A systematic analysis was conducted among 146 cuproptosis-related genes and clinical information based on independent mRNA and protein datasets to elucidate the potential mechanisms and prognostic prediction value of cuproptosis-related genes. A 10-cuproptosis-related gene prediction model was constructed, and its effects on cholangiocarcinoma prognosis were signiﬁcantly connected to poor patient survival. Additionally, the expression patterns of our model included genes that were validated with several cholangiocarcinoma cancer cell lines and a normal biliary epithelial cell line. Results: First, a 10-cuproptosis-related gene signature (ADAM9, ADAM17, ALB, AQP1, CDK1, MT2A, PAM, SOD3, STEAP3, and TMPRSS6) displayed excellent predictive performance for the overall survival of cholangiocarcinoma. The low-cuproptosis group had a signiﬁcantly better prognosis than the high-cuproptosis group with transcriptome and protein cohorts. Second, compared with the high-risk and low-risk groups, the 2 groups displayed distinct tumor microenvironments, reduced proportions of endothelial cells, and increased levels of cancer-associated ﬁbroblasts based on CIBERSORTx and EPIC analyses. Third, patients’ sensitivities to chemotherapeutic drugs and immune checkpoints revealed distinctive differences between the 2 groups. Finally, in replicating the expression patterns of the 10 genes, these results were validated with quantitative real-time polymerase chain reaction results validating the abnormal expression pattern of the target genes in cholangiocarcinoma. Conclusions: Collectively, we established and veriﬁed an effective prognostic model that could separate cholangiocarcinoma patients into 2 heterogeneous cuproptosis subtypes based on the molecular or protein characteristics of 10 cuproptosis-related genes. These ﬁndings may provide potential beneﬁts for unveiling molecular characteristics and deﬁning subgroups could improve the early diagnosis and individualized treatment of cholangiocarcinoma patients.  \nKeywords  \ncholangiocarcinoma, cuproptosis, prognostic biomarker, tumor microenvironment, comprehensive analysis  \nAbbreviations  \nCCA, cholangiocarcinoma; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus; NGDC, National Genomics Data Center; DEGs, differentially expressed genes; OS, overall survival; CA19-9, carbohydrate antigen 19-9; KEGG, Kyoto Encyclopedia of Genes and Genomes; K-M, Kaplan-Meier analysis; qRT-PCR, quantitative real-time PCR; ROC,  \n1 Department of Gastroenterology, Afﬁliated Hangzhou First People’s Hospital, Westlake University School of Medicine, Hangzhou, China  \n2 The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China  \n3 Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, China  \n4 Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou, China  \n5 Hangzhou","cbCaisqkeMHlnOYu","https://ap.wps.com/l/cbCaisqkeMHlnOYu","pdf",5571691,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What is cuproptosis and why is it studied in cholangiocarcinoma?\",\"answer\":\"Cuproptosis is presented as a novel mediated cell death type associated with cancer progression. The document focuses on clarifying its role in cholangiocarcinoma for prognosis prediction, subgroup classification, and therapy strategies.\"},{\"question\":\"How was the prognostic model for cholangiocarcinoma developed?\",\"answer\":\"The study performed a systematic analysis of 146 cuproptosis-related genes using independent mRNA and protein datasets. A 10-cuproptosis-related gene prediction model was constructed and evaluated for survival association.\"},{\"question\":\"What differences were found between low- and high-cuproptosis groups?\",\"answer\":\"The low-cuproptosis group showed significantly better prognosis. The two groups also displayed distinct tumor microenvironments, including differences in endothelial cell proportions and cancer-associated fibroblasts, along with differences in immune checkpoint and chemotherapeutic drug sensitivities.\"}]","Identiﬁcation of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma - Article | PDF",1790020033,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bc9ad208d0cdf057c1d4baec68ddb86.webp",983,1276,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52bcf4a1b752030e8e88bf6750630a61.webp",982,1275,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9286cfd8b81074da359de39833961701.webp",981,1273,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4f443aa48c795615d53e0d74e93cb06.webp",980,1272]